Results 61 to 70 of about 4,529 (167)
Vascular Health and Risk Management, 2008 André C Schmidt1, Burkhard Flick1, Elke Jahn2, Peter Bramlage31Charité – Universitätsmedizin Berlin, Institute for Clinical Pharmacology and Toxikology, Berlin, Germany; 2Berlin-Chemie AG, Clinical Research and Medical ...
André C Schmidt +3 more
doaj
International Journal of Hypertension, 2017 Background. High value of neutrophil lymphocyte ratio (NLR) is a strong independent predictor and biomarker of ongoing vascular inflammation in various cardiovascular disorders. Objective.
Mazhar Hussain +4 more
doaj +1 more source
Nebivolol induced hyperkalemia: case report
Acta Clinica Croatica, 2016 In this article, we document a conclusive case of nebivolol-induced hyperkalemia for the first time in the known medical literature. Hyperkalemia is associated with serious conditions such as cardiac arrhythmias and sudden cardiac death.
Karmela Altabas +2 more
doaj +1 more source
Al-Mustansiriyah Journal of Pharmaceutical SciencesLiver injury can arise post-exposure to drugs or their metabolites, as well as herbal and dietary supplements. Tamoxifen is a frequently used drug in breast cancer treatment.
Noor Ahmed Hammadi +2 more
doaj +1 more source
Use of nebivolol in patients with mild and moderate hypertensive disease
Терапевтический архив, 2003 Aim. To evaluate the effectiveness and safety of the beta-adrenoblocker nebivolol in patients with mild and moderate essential hypertension. Material and methods. The trial enrolled 20 patients.
L V Zhigunova, Ye L Lakhova, A P Yurenev
doaj
Pulmonary effects of nebivolol
Therapeutic Advances in Cardiovascular Disease, 2009 The pharmacological control of arterial hypertension is a very frequent issue in clinical practice and some critical aspects can arise in particular circumstances and with particular molecules. In the case of hypertensive subjects with respiratory comorbidities, when first introduced, these β-adrenergic receptor antagonists were described as affecting
openaire +2 more sources
КардиоСоматика, 2013 Objective: to evaluate the antihypertensive efficacy and effect of nebivolol and valsartan on metabolic parameters and erective function in patients with hypertension, metabolic syndrome, and erectile dysfunction. Subjects and methods.
S. V Nedogoda +5 more
doaj
Кардиоваскулярная терапия и профилактика, 2006 Aim. To assess nebivolol clinical effects on intravascular platelet activity in patients with arterial hypertension (AH) and metabolic syndrome (MS). Material and methods. In total, 21 patients were administered nebivolol (5 mg/d) for one month. Dynamics
I. N. Medvedev
doaj
National Journal of Physiology, Pharmacy and PharmacologyBackground: Breast cancer (BC) has become the most common cancer among women in India. Both amlodipine, belonging to calcium channel blockers, and nebivolol, belonging to the beta blockers class have proven anticancer mechanisms.
Hemalatha A +4 more
doaj +1 more source
Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy
Кардиоваскулярная терапия и профилактика, 2010 Background: Impaired coronary flow reserve (CFR) is a significant predictor of poor prognosis in patients with idiopathic dilated cardiomyopathy (IDC).
Dogan Erdogan +6 more
doaj